A detailed history of New Millennium Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New Millennium Group LLC holds 42 shares of BMY stock, worth $2,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 42 -0.0%
Holding current value
$2,387
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $1,690 - $2,225
42 New
42 $1,000
Q4 2023

Jan 17, 2024

SELL
$48.48 - $57.85 $4,702 - $5,611
-97 Reduced 70.29%
41 $2,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $3,878 - $4,336
67 Added 94.37%
138 $8,000
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $19,049 - $21,151
-299 Reduced 80.81%
71 $4,000
Q1 2023

Apr 28, 2023

SELL
$65.71 - $74.53 $2,234 - $2,534
-34 Reduced 8.42%
370 $25,000
Q4 2022

Feb 07, 2023

BUY
$68.48 - $81.09 $1,506 - $1,783
22 Added 5.76%
404 $29,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $2 - $1,613
-21 Reduced 5.21%
382 $27,000
Q2 2022

Aug 18, 2022

BUY
$72.62 - $79.98 $29,265 - $32,231
403 New
403 $31,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.